A. Nangouma

Effectiveness of a 10-day melarsoprol schedule for the treatment of late-stage human African trypanosomiasis: confirmation from a multinational study (IMPAMEL II).

C. Burri, F. Chappuis, P. Simarro, 2005, The Journal of infectious diseases.

Entomological profile of yellow fever epidemics in the Central African Republic, 2006–2010

A. Manirakiza, C. Paupy, E. Nakouné, 2012, Parasites & Vectors.

Dot Enzyme-Linked Immunosorbent Assay for More Reliable Staging of Patients with Human African Trypanosomiasis

S. Bisser, T. Josénando, B. Courtioux, 2005, Journal of Clinical Microbiology.

Evaluation of the micro-CATT, CATT/Trypanosoma brucei gambiense, and LATEX/T b gambiense methods for serodiagnosis and surveillance of human African trypanosomiasis in West and Central Africa.

V. Jamonneau, D. Verloo, P. Büscher, 2002, Bulletin of the World Health Organization.

First record of Ae. albopictus (Skuse 1894), in Central African Republic

M. Diallo, A. Nangouma, R. Laganier, 2010, Tropical medicine & international health : TM & IH.

[Cost of a national program to control human African trypanosomiasis in the high Mbomou region, Central African Republic].

P. Simarro, J. Franco, J. A. Ruiz Postigo, 2001, Medecine tropicale : revue du Corps de sante colonial.

Yellow fever risk assessment in the Central African Republic.

Rosamund F. Lewis, B. Biggerstaff, J. E. Staples, 2014, Transactions of the Royal Society of Tropical Medicine and Hygiene.